Press Releases

Investor Resources
Contact Us
Investor ResourcesPress Releases

Press Releases

Cardiol Therapeutics Completes Initial Public Offering and the Company’s Common Shares and Warrants Commence Trading on the Toronto Stock Exchange Under the Symbols “CRDL” and “CRDL.WT”


December 20, 2018

Cardiol Therapeutics Appoints Mr. Chris Waddick as Chief Financial Officer, Ms. Anne Tomalin as Director of Regulatory Affairs, and Ms. Dolly Kao as Intellectual Property Counsel


August 30, 2018

Cardiol Therapeutics Appoints Dr. Eldon Smith as Chairman and Dr. Guillermo Torre-Amione, Ms. Deborah Brown, and Mr. Iain Chalmers to its Board of Directors


August 21, 2018

Cardiol Therapeutics Closes $10.5 Million Private Placement


May 24, 2018

Cardiol Therapeutics Appoints Dr. James Young as Chair of the Company’s Scientific Advisory Board


May 8, 2018

Cardiol Therapeutics to Present at the 2018 BIO CEO & Investor Conference in NYC


February 6, 2018

Cardiol Therapeutics Demonstrates Novel Way to Target Drugs for Treating Heart Failure Using Nanotechnology


January 9, 2018

Cardiol Therapeutics to Present at the 2018 Biotech Showcase in San Francisco


January 3, 2018

2024 Cardiol Therapeutics. All right reserved.